Genomic Medicine in Emerging Economies

Dr. George Patrinos is an Associate Professor at the University of Patras School of Health Sciences (Department of Pharmacy) in Patras, Greece with Adjunct positions in Rotterdam, the Netherlands and Al-Ain, United Arab Emirates. His research interests span the fields of molecular diagnostics, high-throughput mutation screening, the development of online mutation diagnostic tools, and the implementation of genomics into healthcare, particularly for health systems in developing countries. George Patrinos has published more than 170 scientific papers in peer reviewed journals on topics related to genetics, genomic medicine, pharmacogenomics, molecular diagnostics, and social and economic evaluation for genomic medicine. Dr. Patrinos is also the co-author of Economic Evaluation in Genomic Medicine (2015) and co-Editor of Molecular Diagnostics, Second Edition (2009), both published by Elsevier, and serves as Communicating Editor for the journal Human Mutation. Additionally, he is co-organizer of the international meeting series “Golden Helix Symposia” and “Golden Helix Pharmacogenomics Days”. Dr. Catalina Lopez-Correa MD, PhD is Chief Scientific Officer and Executive Director of the Canadian COVID19 Genomics Network (CanCOGeN) at Genome Canada. Before that she was Chief Operating Officer at Ruta N Medellin. She has 20 years of international experience in genomics in both the academic and private sectors. Before Ruta N, she was Chief Scientific Officer for Genome British Columbia and Genome Quebec and held senior research positions with pharmaceutical giant Eli Lilly and with deCODE genetics in Iceland. As CSO at Genome BC and Genome Quebec she coordinated several initiatives to help understand and address the social, legal, ethical, economical aspects of genomics. Dr. Lopez-Correa has been a national and international champion of equity, diversity, and inclusion in genomics and science in general.

1. Genomic Medicine in developing and emerging economies: State-of-the-art and future trends 2. Taking genomics from the bench to the bedside in developing countries 3. Genomics and Public Health: China’s Perspective 4. Leveraging International Collaborations to Advance Genomic Medicine in Colombia 5. Screening for hereditary cancer in Latin America 6. Implementing Genomics in the Care of Neuropsychiatric Patients in Latin America 7. Experience in the development of genomics companies during the last 20 years in Argentina 8. Economic evaluation and cost-effectiveness analysis of genomic medicine interventions in developing and emerging countries 9. Raising genomics awareness among the general public and educating healthcare professionals on Genomic Medicine 10. The Genomic Medicine Alliance: A global effort to facilitate the introduction of genomics into healthcare in developing nations